CTNNB1 and malignant colon neoplasm: In fact, Pyrvinium pamoate, an anti-helminth drug, was shown to decrease PYGO2 protein levels in colon cancer cells lines with Apc and Ctnnb1 mutations [92], and in ApcMin/+ mice [93].